Toledo Community Oncology Program Logo

Member Login Phone: 419-843-6147
Email: info@tcop.info

Treatment Today, Progress Tomorrow

Simply stated, clinical trials are research studies wherein participating patients, along with their physician, have the opportunity to discover new and better ways to improve the treatment of cancer. The Toledo Community Oncology Program (TCOP) is a member of the National Cancer Institute’s (NCI) Community Clinical Oncology Program (CCOP). CCOP is a comprehensive clinical trial network that brings the latest adult cancer prevention and treatment research findings to communities across the nation. Formed in 1983, CCOP brings together community physicians with the medical industry’s leading scientists to conduct NCI-supported clinical trials. As a regional CCOP, TCOP offers participation in these life-saving trials in northwest Ohio, northeast Ohio, southeast Michigan, Fredericksburg, Virginia and Butler, Pennsylvania. TCOP benefits both patients and physicians in these communities — providing treatment for today and progress for tomorrow.


ABOUT CLINICAL TRIALS

Developed to target and review the effectiveness of various and promising approaches to cancer prevention, detection, diagnosis and treatment, cancer trials allow specific clinical questions to be answered quickly, utilizing the latest research findings. One of the final stages of a long and careful cancer research process, these research studies can take various forms, including treatment trials, screening trials, quality of life trials, and prevention trials.

 

Clinical trials are classified into one of three phases. Phase I trials evaluate how a new drug should be given, how often, and at what dosage. These trials are done in small numbers, usually to those with advanced stages of the illness. Phase II trials are formed to evaluate the benefits of particular new drugs for particular types of cancer. Finally, Phase III trials compare a new drug or procedure with another, usually a more standard drug or procedure. TCOP deals mainly with Phase II and III trials, helping to define which drugs and procedures best treat the specific cancer.

 

Clinical trials go through many steps to ensure that they are conducted in a safe manner. Before a clinical trial can be opened in a community, it must be approved by an Institutional Review Board (IRB). An IRB is comprised of health professionals as well as community members. TCOP has 17 IRB members including clergy, physicians, nurses and community members.

 

Click on "Learn About Trails" above to discover more about clinical trials, the questions to ask your physicians, clarification on common misconceptions, and specifics on insurance issues.